189 related articles for article (PubMed ID: 23877010)
1. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
[TBL] [Abstract][Full Text] [Related]
3. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.
Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH
Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169
[TBL] [Abstract][Full Text] [Related]
4. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
[TBL] [Abstract][Full Text] [Related]
5. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.
Brodmerkel CM; Huber R; Covington M; Diamond S; Hall L; Collins R; Leffet L; Gallagher K; Feldman P; Collier P; Stow M; Gu X; Baribaud F; Shin N; Thomas B; Burn T; Hollis G; Yeleswaram S; Solomon K; Friedman S; Wang A; Xue CB; Newton RC; Scherle P; Vaddi K
J Immunol; 2005 Oct; 175(8):5370-8. PubMed ID: 16210643
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
[TBL] [Abstract][Full Text] [Related]
7. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
[TBL] [Abstract][Full Text] [Related]
8. High-content analysis of CCR2 antagonists on human primary monocytes.
Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
10. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
[TBL] [Abstract][Full Text] [Related]
11. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.
Van Steenwinckel J; Reaux-Le Goazigo A; Pommier B; Mauborgne A; Dansereau MA; Kitabgi P; Sarret P; Pohl M; Mélik Parsadaniantz S
J Neurosci; 2011 Apr; 31(15):5865-75. PubMed ID: 21490228
[TBL] [Abstract][Full Text] [Related]
12. CCL2 binding is CCR2 independent in primary adult human astrocytes.
Fouillet A; Mawson J; Suliman O; Sharrack B; Romero IA; Woodroofe MN
Brain Res; 2012 Feb; 1437():115-26. PubMed ID: 22226505
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in CCR2 antagonists.
Xia M; Sui Z
Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
[TBL] [Abstract][Full Text] [Related]
14. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
15. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
16. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
17. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
Kang YS; Cha JJ; Hyun YY; Cha DR
Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
[TBL] [Abstract][Full Text] [Related]
18. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats.
Dansereau MA; Gosselin RD; Pohl M; Pommier B; Mechighel P; Mauborgne A; Rostene W; Kitabgi P; Beaudet N; Sarret P; Melik-Parsadaniantz S
J Neurochem; 2008 Jul; 106(2):757-69. PubMed ID: 18419759
[TBL] [Abstract][Full Text] [Related]
19. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
Singh R; Sobhia ME
J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocation.
Favre N; Camps M; Arod C; Chabert C; Rommel C; Pasquali C
Proteomics; 2008 Nov; 8(21):4560-76. PubMed ID: 18846510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
